Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
EUROAPI logo — Active Solutions for Health

EUROAPI

Active Solutions for Health

Founded 2021 France France 1483 employees Post-IPO Debt Total: $755.00M Health Care, Manufacturing

General Information

Company Name EUROAPI
Founded Year 2021
Location France France
Employees 1483
Industries Health Care, Manufacturing
Funding Stage Post-IPO Debt
Business Model B2B, B2B2B
Revenue Model Product Sales, Service Fee, Licensing
Social

BounceWatch is an independent company data service, not affiliated with EUROAPI. To contact EUROAPI, visit euroapi.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does EUROAPI compare?

A PDF of EUROAPI and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting EUROAPI soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About EUROAPI

EUROAPI, founded in 2021, is a leading player in the Health Care and Manufacturing industries, specializing in the production of active pharmaceutical ingredients (APIs). With a broad portfolio of approximately 200 products, the company operates under the slogan "Active Solutions for Health." Their emphasis on research and development, combined with a strong European manufacturing presence, enables them to deliver high-quality API solutions worldwide.

Headquartered in France, EUROAPI manages six manufacturing sites across Europe, ensuring product distribution in over 80 countries. This European industrial platform is recognized for its reliability, quality, and premium client service. The company’s commitment to sustainability and stakeholder satisfaction is central to its operations, as reflected in their vision and mission statements.

The company recently secured a €755.00M post-IPO debt investment from Sanofi as of October 10, 2024. Listed on Euronext Paris, EUROAPI is well-positioned for continued growth and innovation in the pharmaceutical sector.

Business keywords: Active Pharmaceutical Ingredients, Contract Development and Manufacturing Organization, API Manufacturing, Innovative Molecules, Pharmaceutical Standards, Small Molecules, Drug Delivery Solutions, Custom Development, Microbial Fermentation, Particle Engineering, Spray-drying, Micronization, Oligonucleotides and Peptides, Vitamin B12 Production, Prostaglandins and Alkaloids

Services & Products

API Solutions
CDMO Services
Industrial Network Support

Target Customers

Pharmaceutical Companies Biotech Firms Healthcare Providers Animal Health Companies

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Debt €755.00M 1
Sanofi
10 Oct 2024

EUROAPI Alternatives & Competitors

View All Alternatives
EUROAPI vs
Avra Laboratories Pvt Ltd
Avra Laboratories Pvt Ltd India

Custom Synthesis from Idea to Market

210 employees
Biotechnology, Health Care
EUROAPI vs
Delpharm
Delpharm France

A worldwide leader in contract development and manufacturing of medicines

Late Stage
3905 employees
Health Care, Manufacturing
EUROAPI vs
Axplora
Axplora Germany

Reliable partner. Agile explorer.

696 employees
Biotechnology, Health Care
Compare EUROAPI vs Axplora
View all alternatives

FAQ About EUROAPI

Active Solutions for Health
EUROAPI was founded in 2021.
EUROAPI is headquartered in France.
EUROAPI operates in Health Care and Manufacturing. Its work centres on Active Pharmaceutical Ingredients, Contract Development and Manufacturing Organization, API Manufacturing and Innovative Molecules. Its customers include Pharmaceutical Companies, Biotech Firms and Healthcare Providers.
EUROAPI has a B2B and B2B2B business model. Its revenue comes from Product Sales, Service Fee and Licensing.
EUROAPI has approximately 1483 employees.
EUROAPI has completed 1 funding round, raising a total of $755.00M. The latest funding stage is Post-IPO Debt.
EUROAPI offers: API Solutions, CDMO Services, Industrial Network Support.
Top alternatives and competitors to EUROAPI include Avra Laboratories Pvt Ltd, Delpharm, Axplora, FUJIFILM Biotechnologies, Chempro Pharma Pvt. Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
EUROAPI and Avra Laboratories Pvt Ltd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for EUROAPI, https://bouncewatch.com/company/euroapi, updated 17 March 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout